Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0000876661-24-001036
Filing Date
2024-11-04
Accepted
2024-11-04 10:05:27
Documents
2
Effectiveness Date
2024-11-04

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1074
2 ruleprovisionnotice.htm EX-99.25 766
  Complete submission text file 0000876661-24-001036.txt   3745
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Subject) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 001-06571 | Film No.: 241421162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11 WALL STREET NEW YORK NY 10005
Business Address 11 WALL STREET NEW YORK NY 10005 212-656-2060
NEW YORK STOCK EXCHANGE LLC (Filed by) CIK: 0000876661 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY
Type: 25-NSE